BioInvent: Interview with CEO Martin Welschof and CMO Andres McAllister about the new BI-1808 results
12 juni, 09:30
12 juni, 09:30
Redeye interviews CEO Martin Welschof and CMO Andres McAllister about BI-1808 in T-cell lymphoma.
12 juni, 09:30
Redeye interviews CEO Martin Welschof and CMO Andres McAllister about BI-1808 in T-cell lymphoma.
Veckans analyser
Fortnox-budet
Veckans analyser
Fortnox-budet
1 DAG %
Senast
Creades
13 juni, 18:51
Creades och Bure gör stor halvledarinvestering
OMX Stockholm 30
1 DAG %
Senast
2 459,61